Reinhart Partners LLC. Sells 31,105 Shares of Encompass Health Corporation $EHC

Reinhart Partners LLC. lessened its position in Encompass Health Corporation (NYSE:EHC) by 7.1% in the third quarter, HoldingsChannel reports. The fund owned 404,257 shares of the company’s stock after selling 31,105 shares during the quarter. Reinhart Partners LLC.’s holdings in Encompass Health were worth $49,113,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Gamco Investors INC. ET AL lifted its holdings in shares of Encompass Health by 2.0% in the 1st quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company’s stock worth $466,000 after purchasing an additional 94 shares in the last quarter. Gibson Capital LLC increased its stake in Encompass Health by 4.3% during the 1st quarter. Gibson Capital LLC now owns 2,431 shares of the company’s stock valued at $235,000 after purchasing an additional 101 shares in the last quarter. GAMMA Investing LLC raised its holdings in Encompass Health by 2.7% during the second quarter. GAMMA Investing LLC now owns 3,969 shares of the company’s stock worth $401,000 after buying an additional 106 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of Encompass Health by 21.8% in the second quarter. Versant Capital Management Inc now owns 720 shares of the company’s stock valued at $73,000 after buying an additional 129 shares in the last quarter. Finally, QRG Capital Management Inc. grew its holdings in shares of Encompass Health by 1.5% during the first quarter. QRG Capital Management Inc. now owns 8,639 shares of the company’s stock valued at $836,000 after buying an additional 130 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Encompass Health

In related news, EVP John Darby sold 4,858 shares of Encompass Health stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,086,714.69. This trade represents a 6.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares in the company, valued at approximately $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 186,912 shares of company stock worth $23,434,845. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Price Performance

EHC opened at $123.33 on Friday. The firm has a market cap of $12.17 billion, a P/E ratio of 20.09, a PEG ratio of 2.48 and a beta of 0.74. The firm has a 50-day moving average of $121.57 and a 200 day moving average of $110.57. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter in the previous year, the firm posted $1.40 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, research analysts expect that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.7%. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio is currently 13.68%.

Analyst Ratings Changes

EHC has been the subject of several recent research reports. Barclays boosted their target price on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Truist Financial lifted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 7th. TD Cowen boosted their price objective on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, August 10th. UBS Group increased their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Raymond James Financial set a $150.00 target price on Encompass Health in a report on Monday, September 28th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $148.50.

Encompass Health Company Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company focused on inpatient rehabilitation. Through its network of rehabilitation hospitals, the company provides intensive medical and therapeutic care to patients recovering from conditions such as strokes, brain and spinal cord injuries, hip fractures, amputations, neurological disorders, and other disabling illnesses or injuries.

Its rehabilitation hospitals offer coordinated care from physicians, nurses, therapists, and other healthcare professionals.